Transcatheter bronchial arterial chemoembolization is a minimally invasive operation. To put it simply, in the case of no operation, a tiny channel with a diameter of about 2 mm is made on the skin. Under the guidance of angiography machine, the tumor blood supply vessels are found and then the chemotherapy drugs are infused through the catheter, and then the tumor blood vessel is embolized with embolization agent to block the tumor blood supply. For the tumor is to kill (high concentration of anticancer drugs) + "starve to death (blocking tumor blood vessels) double treatment of the tumor, the local lesions for the least trauma treatment method.

This report contains market size and forecasts of Lung Tumor Embolization in Global, including the following market information:

 

 

  • Global Lung Tumor Embolization Market Revenue, 2018-2023, 2023-2030, ($ millions)
  • Global top five companies in 2022 (%)

 

 

The global Lung Tumor Embolization market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.

Transarterial chemoembolization (TACE) Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Lung Tumor Embolization include Inari Medical, Penumbra, Tendfo, Medtronic and Olympus, etc. In 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Lung Tumor Embolization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lung Tumor Embolization Market, by Type, 2018-2023, 2023-2030 ($ millions)

Global Lung Tumor Embolization Market Segment Percentages, by Type, 2022 (%)

 

  • Transarterial chemoembolization (TACE)
  • Transarterial Radioembolization (TARE)
  • Others

 

Global Lung Tumor Embolization Market, by Application, 2018-2023, 2023-2030 ($ millions)

Global Lung Tumor Embolization Market Segment Percentages, by Application, 2022 (%)

 

  • Hospitals
  • Ambulatory Surgical Centers

 

Global Lung Tumor Embolization Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)

Global Lung Tumor Embolization Market Segment Percentages, By Region and Country, 2022 (%)

 

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

 

Competitor Analysis

The report also provides analysis of leading market participants including:

 

  • Key companies Lung Tumor Embolization revenues in global market, 2018-2023 (estimated), ($ millions)
  • Key companies Lung Tumor Embolization revenues share in global market, 2022 (%)

 

Further, the report presents profiles of competitors in the market, key players include:

 

  • Inari Medical
  • Penumbra
  • Tendfo
  • Medtronic
  • Olympus


Table of content

1 Introduction to Research & Analysis Reports
1.1 Lung Tumor Embolization Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Tumor Embolization Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Tumor Embolization Overall Market Size
2.1 Global Lung Tumor Embolization Market Size: 2022 VS 2030
2.2 Global Lung Tumor Embolization Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Tumor Embolization Players in Global Market
3.2 Top Global Lung Tumor Embolization Companies Ranked by Revenue
3.3 Global Lung Tumor Embolization Revenue by Companies
3.4 Top 3 and Top 5 Lung Tumor Embolization Companies in Global Market, by Revenue in 2022
3.5 Global Companies Lung Tumor Embolization Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Tumor Embolization Players in Global Market
3.6.1 List of Global Tier 1 Lung Tumor Embolization Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Tumor Embolization Companies
4 Market Sights by Product
4.1 Overview


CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414


Similar Reports:

Global Lung Tumor Embolization Market Research Report 2023